US Stock MarketDetailed Quotes

CalciMedica (CALC)

Watchlist
  • 5.376
  • +0.036+0.67%
Trading Jan 23 11:01 ET
77.46MMarket Cap-3.32P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CalciMedica (CALC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-2.06%5.62M
1.41%6.62M
12.66%6.5M
-36.43%24.2M
42.90%6.17M
18.68%5.74M
-0.82%6.53M
-74.19%5.77M
168.27%38.08M
39.10%4.32M
Selling and administrative expenses
-19.32%1.77M
8.31%2.57M
-19.48%2.27M
-56.22%9.73M
52.31%2.34M
6.26%2.19M
-14.34%2.37M
-82.19%2.82M
280.22%22.22M
29.92%1.54M
-General and administrative expense
-19.32%1.77M
8.31%2.57M
-19.48%2.27M
-56.22%9.73M
52.31%2.34M
6.26%2.19M
-14.34%2.37M
-82.19%2.82M
280.22%22.22M
29.92%1.54M
Research and development costs
8.60%3.85M
-2.53%4.05M
43.48%4.22M
-8.71%14.48M
37.71%3.83M
27.92%3.55M
8.99%4.16M
-54.64%2.94M
89.93%15.86M
44.75%2.78M
Operating profit
2.06%-5.62M
-1.41%-6.62M
-12.66%-6.5M
36.43%-24.2M
-42.90%-6.17M
-18.68%-5.74M
0.82%-6.53M
74.19%-5.77M
-168.27%-38.08M
-39.10%-4.32M
Net non-operating interest income expense
-185.32%-186K
-137.82%-104K
-447K
218K
275K
0
Non-operating interest income
-35.78%140K
-20.00%220K
----
----
----
--218K
--275K
----
----
----
Non-operating interest expense
--326K
--324K
--447K
----
----
--0
--0
--0
----
----
Other net income (expense)
-1,900.00%-2M
-66.57%769K
-67.75%1.9M
182.52%10.5M
1,468.79%2.71M
-146.73%-100K
724.37%2.3M
93.22%5.9M
-42.81%3.72M
-96.28%173K
Gain on sale of security
-1,900.00%-2M
-78.26%500K
-69.59%1.7M
199.56%9.49M
--1.7M
---100K
--2.3M
76.45%5.59M
-51.48%3.17M
--0
Other non- operating income (expenses)
----
-2.18%269K
-34.20%202K
84.36%1.01M
23.70%214K
1.87%218K
-1.43%275K
364.66%307K
2,064.29%550K
246.00%173K
Income before tax
-38.91%-7.8M
-50.63%-5.96M
-3,978.46%-5.04M
60.12%-13.7M
-2.70%-4.26M
-21.63%-5.62M
37.28%-3.95M
100.67%130K
-339.12%-34.36M
-392.59%-4.15M
Income tax
Net income
-38.91%-7.8M
-50.63%-5.96M
-3,978.46%-5.04M
60.12%-13.7M
-2.70%-4.26M
-21.63%-5.62M
37.28%-3.95M
100.67%130K
-339.12%-34.36M
-392.59%-4.15M
Net income continuous Operations
-38.91%-7.8M
-50.63%-5.96M
-3,978.46%-5.04M
60.12%-13.7M
-2.70%-4.26M
-21.63%-5.62M
37.28%-3.95M
100.67%130K
-339.12%-34.36M
-392.59%-4.15M
Minority interest income
Net income attributable to the parent company
-38.91%-7.8M
-50.63%-5.96M
-3,978.46%-5.04M
60.12%-13.7M
-2.70%-4.26M
-21.63%-5.62M
37.28%-3.95M
100.67%130K
-339.12%-34.36M
-392.59%-4.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.91%-7.8M
-50.63%-5.96M
-3,978.46%-5.04M
60.12%-13.7M
-2.70%-4.26M
-21.63%-5.62M
37.28%-3.95M
100.67%130K
-275.81%-34.36M
-4,287.88%-4.15M
Basic earnings per share
-4.00%-0.52
-11.11%-0.4
-3,700.00%-0.36
84.07%-1.22
-47.83%-0.34
39.02%-0.5
67.57%-0.36
100.04%0.01
93.11%-7.66
-111.06%-0.23
Diluted earnings per share
-4.00%-0.52
-11.11%-0.4
-3,700.00%-0.36
84.07%-1.22
-47.83%-0.34
39.02%-0.5
67.57%-0.36
100.04%0.01
93.11%-7.66
-111.06%-0.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -2.06%5.62M1.41%6.62M12.66%6.5M-36.43%24.2M42.90%6.17M18.68%5.74M-0.82%6.53M-74.19%5.77M168.27%38.08M39.10%4.32M
Selling and administrative expenses -19.32%1.77M8.31%2.57M-19.48%2.27M-56.22%9.73M52.31%2.34M6.26%2.19M-14.34%2.37M-82.19%2.82M280.22%22.22M29.92%1.54M
-General and administrative expense -19.32%1.77M8.31%2.57M-19.48%2.27M-56.22%9.73M52.31%2.34M6.26%2.19M-14.34%2.37M-82.19%2.82M280.22%22.22M29.92%1.54M
Research and development costs 8.60%3.85M-2.53%4.05M43.48%4.22M-8.71%14.48M37.71%3.83M27.92%3.55M8.99%4.16M-54.64%2.94M89.93%15.86M44.75%2.78M
Operating profit 2.06%-5.62M-1.41%-6.62M-12.66%-6.5M36.43%-24.2M-42.90%-6.17M-18.68%-5.74M0.82%-6.53M74.19%-5.77M-168.27%-38.08M-39.10%-4.32M
Net non-operating interest income expense -185.32%-186K-137.82%-104K-447K218K275K0
Non-operating interest income -35.78%140K-20.00%220K--------------218K--275K------------
Non-operating interest expense --326K--324K--447K----------0--0--0--------
Other net income (expense) -1,900.00%-2M-66.57%769K-67.75%1.9M182.52%10.5M1,468.79%2.71M-146.73%-100K724.37%2.3M93.22%5.9M-42.81%3.72M-96.28%173K
Gain on sale of security -1,900.00%-2M-78.26%500K-69.59%1.7M199.56%9.49M--1.7M---100K--2.3M76.45%5.59M-51.48%3.17M--0
Other non- operating income (expenses) -----2.18%269K-34.20%202K84.36%1.01M23.70%214K1.87%218K-1.43%275K364.66%307K2,064.29%550K246.00%173K
Income before tax -38.91%-7.8M-50.63%-5.96M-3,978.46%-5.04M60.12%-13.7M-2.70%-4.26M-21.63%-5.62M37.28%-3.95M100.67%130K-339.12%-34.36M-392.59%-4.15M
Income tax
Net income -38.91%-7.8M-50.63%-5.96M-3,978.46%-5.04M60.12%-13.7M-2.70%-4.26M-21.63%-5.62M37.28%-3.95M100.67%130K-339.12%-34.36M-392.59%-4.15M
Net income continuous Operations -38.91%-7.8M-50.63%-5.96M-3,978.46%-5.04M60.12%-13.7M-2.70%-4.26M-21.63%-5.62M37.28%-3.95M100.67%130K-339.12%-34.36M-392.59%-4.15M
Minority interest income
Net income attributable to the parent company -38.91%-7.8M-50.63%-5.96M-3,978.46%-5.04M60.12%-13.7M-2.70%-4.26M-21.63%-5.62M37.28%-3.95M100.67%130K-339.12%-34.36M-392.59%-4.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.91%-7.8M-50.63%-5.96M-3,978.46%-5.04M60.12%-13.7M-2.70%-4.26M-21.63%-5.62M37.28%-3.95M100.67%130K-275.81%-34.36M-4,287.88%-4.15M
Basic earnings per share -4.00%-0.52-11.11%-0.4-3,700.00%-0.3684.07%-1.22-47.83%-0.3439.02%-0.567.57%-0.36100.04%0.0193.11%-7.66-111.06%-0.23
Diluted earnings per share -4.00%-0.52-11.11%-0.4-3,700.00%-0.3684.07%-1.22-47.83%-0.3439.02%-0.567.57%-0.36100.04%0.0193.11%-7.66-111.06%-0.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.80%
Sample Name
Sample Code
 +3.64%
Sample Name
Sample Code
 +2.48%
4
Netflix
NFLX
+1.92%
5
Clean Energy Fuels
CLNE
+1.54%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.10%
Sample Name
Sample Code
 +8.76%
Sample Name
Sample Code
 +4.54%
4
H World Group
HTHT
+4.28%
5
KE Holdings
BEKE
+4.22%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -